Linda Lennox | VP, IR & Corporate Communications |
William Heiden | CEO and Director |
Nicholas Grund | EVP & Chief Commercial Officer |
Julie Krop | EVP & Chief Medical Officer |
Edward Myles | EVP & CFO |
Jessica Fye | JPMorgan Chase & Co. |
Esther Rajavelu | Deutsche Bank AG |
Kyung Yang | Jefferies |
Joseph Schwartz | Leerink Partners |
Kenneth Trbovich | Janney Montgomery Scott |
William Tanner | Cantor Fitzgerald & Co. |
David Buck | B. Riley FBR, Inc. |
Good morning. My name is Kim, and I will be your conference operator today. At this time, I would like to welcome everyone to the AMAG Pharmaceuticals First Quarter 2018 Earnings Call. [Operator Instructions]. It is now my pleasure to turn today's call over to Ms.